Brief: Arix Bioscience Says Sale Of Harpoon Is Expected To Deliver Net Proceeds Of About $18.9 Mln

Arix Bioscience

19/01/2024 07:21

Jan 19 (Reuters) - Arix Bioscience PLC  ARIX.L :
    * MERCK THROUGH UNIT, AGREED TO ACQUIRE HARPOON FOR $23.00
PER
SHARE IN CASH FOR AN APPROXIMATE TOTAL EQUITY VALUE OF $680
MILLION
    * FINANCIAL UPDATE ON HARPOON THERAPEUTICS ACQUISITION BY
MERCK
(MSD)
    * SALE OF HARPOON IS EXPECTED TO DELIVER NET PROCEEDS TO
ARIX OF
APPROXIMATELY $18.9 MILLION (£14.9 MILLION)

Source text for Eikon:  ID: 
Further company coverage:  ARIX.L 

 ((Reuters.Briefs@thomsonreuters.com;))